本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

諾和諾德

64.31
-0.9800-1.50%
盤後64.490.1800+0.28%19:59 EDT
成交量:805.12萬
成交額:5.20億
市值:2,854.75億
市盈率:18.91
高:65.79
開:65.67
低:64.16
收:65.29
資料載入中...
2025/06/27

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/06/27

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/05/30

關聯方擬減持公告

Form 144 | Innate Pharma SA 10% 股東 Novo Nordisk A/S 擬減持921897股,總價約197萬美元
2025/02/05

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/21

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/21

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/01/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/11/24

SEC問詢函

Form CORRESP - Correspondence
2023/11/09

SEC問詢函

Form CORRESP - Correspondence
2023/10/20

SEC問詢函

Form CORRESP - Correspondence
2023/09/29

SEC問詢函

Form CORRESP - Correspondence
2023/09/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/28

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/06/28

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/02/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/28

員工持股計劃

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans
2022/06/28

員工持股計劃

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans
2022/03/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/06/23

員工持股計劃

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans